New Links Between Diabetes, Gut Disease, and Cancer Risk Revealed in Latest Research

This MedPage Today gastroenterology roundup covers a broad range of research findings with direct relevance to disease prevention, chronic illness management, and longevity.

One of the most actionable findings involves new-onset diabetes. A Korean cohort study published in Gut found that patients who required rapid treatment escalation or an intensive initial regimen had a significantly elevated risk of pancreatic cancer compared with non-diabetics. This underscores the importance of monitoring newly diagnosed diabetics carefully, as aggressive diabetes at onset may signal underlying pancreatic pathology rather than simple type 2 disease.

For individuals living with inflammatory bowel disease, new data show that Crohn's disease — but not ulcerative colitis — independently raises the risk of periprosthetic joint infections following joint replacement surgery. This is a clinically important distinction for surgical planning in IBD patients. Separately, the JAK inhibitor tofacitinib showed comparable safety to biologics for ulcerative colitis in a large real-world U.S. study, offering reassurance about its cardiovascular and infection risk profile.

On the gut-brain axis front, a randomized trial published in Gut found that smartphone-delivered, self-guided hypnotherapy reduced IBS-related abdominal pain, pointing to scalable, low-cost digital interventions for a condition affecting millions worldwide.

In liver disease, the WHO reports meaningful progress: hepatitis B infections fell 32% annually since 2015, and hepatitis C mortality declined 12%. A phase III trial also showed an 8-week once-daily pill regimen for hepatitis C was non-inferior to a standard 12-week course, potentially improving treatment adherence.

Finally, colorectal cancer rates are rising among pregnant and postpartum women — a demographic often excluded from screening discussions. Clinicians and health-conscious women should be aware of this trend. Taken together, these findings reinforce the deep connections between metabolic health, inflammation, and cancer risk across organ systems.